Alpine Global Management, LLC Rigel Pharmaceuticals Inc Transaction History

Alpine Global Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 06, 2024	BUY	$1.12 - $1.82 $14,412 - $23,419	12,868 New	12,868 $16,000
Q2 2023 Nov 21, 2023	BUY	$1.12 - $1.82 $14,412 - $23,419	12,868 New	12,868 $16,000
Q2 2023 Aug 14, 2023	BUY	$1.12 - $1.82 $14,412 - $23,419	12,868 New	12,868 $16,000
Q4 2022 Feb 14, 2023	BUY	$0.67 - $11.9 $24,012 - $426,496	35,840 New	35,840 $54,000
Q1 2019 May 10, 2019	SELL	$2.0 - $2.65 $20,264 - $26,849	-10,132 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$2.08 - $3.36 $21,074 - $34,043	10,132 New	10,132 $23,000

334K

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $2.81B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

Get notified when there are updates to the investment portfolio of Alpine Global Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Alpine Global Management, LLC with notifications on news.